Yongjia Cui
Overview
Explore the profile of Yongjia Cui including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
37
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Song Q, Yu Z, Lu W, Zhuo Z, Chang L, Mei H, et al.
Hum Vaccin Immunother
. 2025 Jan;
21(1):2424611.
PMID: 39757956
Programmed cell death-1 (PD-1) inhibitors and programmed cell death ligand 1 (PD-L1) inhibitors are considered effective alternatives for the primary treatment of recurrent metastatic cancers. However, they can induce various...
2.
Zhuo Z, Lu W, Zhang L, Zhang D, Cui Y, Wu X, et al.
Discov Oncol
. 2024 Dec;
15(1):762.
PMID: 39692924
TNBC, the most aggressive form of breast cancer, lacks accurate and effective therapeutic targets. Immunotherapy presents a promising approach for addressing TNBC. Anxiety and depression are frequently concurrent symptoms in...
3.
Zhuo Z, Zhang D, Lu W, Wu X, Cui Y, Zhang W, et al.
Oncol Res
. 2024 Jun;
32(6):1093-1107.
PMID: 38827320
Breast cancer is the leading cause of cancer-related deaths in women worldwide, with Hormone Receptor (HR)+ being the predominant subtype. Tamoxifen (TAM) serves as the primary treatment for HR+ breast...
4.
Cui Y, Zhang W, Lu W, Feng Y, Wu X, Zhuo Z, et al.
Front Immunol
. 2024 Feb;
15:1228235.
PMID: 38404588
Background: Ovarian cancer (OC) has the highest mortality rate among gynecological malignancies. Current treatment options are limited and ineffective, prompting the discovery of reliable biomarkers. Exosome lncRNAs, carrying genetic information,...
5.
Cui Y, Cui S, Lu W, Wang Y, Zhuo Z, Wang R, et al.
Sci Rep
. 2024 Jan;
14(1):1982.
PMID: 38263420
Epidemiological studies have reported a positive association between chronic inflammation and cancer risk. However, the causal association between chronic inflammation and breast cancer (BC) risk remains unclear. Here, we performed...
6.
Wu X, Lu W, Zhang W, Zhang D, Mei H, Zhang M, et al.
Aging (Albany NY)
. 2023 Nov;
15(21):12674-12697.
PMID: 37963845
Background: The treatment of triple-negative breast cancer (TNBC) is one of the main focuses and key difficulties because of its heterogeneity, and the source of this heterogeneity is unclear. Methods:...
7.
Cui Y, Lu W, Shao T, Zhuo Z, Wang Y, Zhang W
PLoS One
. 2023 Sep;
18(9):e0291006.
PMID: 37656762
Background: Based on epidemiological reports, severe mental illness (SMI) and breast cancer (BC) risk are linked positively. However, it is susceptible to clinical confounding factors, such as smoking, alcohol consumption,...
8.
Wu X, Lu W, Jiang C, Zhang D, Zhang W, Cui Y, et al.
PLoS One
. 2023 May;
18(5):e0284825.
PMID: 37141338
Background: Platinum-based chemotherapy is one of the most common treatments for many cancers; however, the effect of chemotherapy varies from individual to individual. Excision repair cross complementation group 1 (ERCC1)...
9.
Wu X, Lu W, Xu C, Jiang C, Zhuo Z, Wang R, et al.
J Immunol Res
. 2023 May;
2023:6455704.
PMID: 37124547
Background: The treatment of platinum-resistant recurrent ovarian cancer (PROC) is a clinical challenge and a hot topic. Tumor microenvironment (TME) as a key factor promoting ovarian cancer progression. Macrophage is...
10.
Wu X, Lu W, Xu C, Jiang C, Zhang W, Zhang D, et al.
Comput Math Methods Med
. 2023 Feb;
2023:2397728.
PMID: 36785673
Background: Ovarian cancer tends to metastasize to the omentum, which is an organ mainly composed of adipose tissue. Many studies have found that fatty acid metabolism is related to the...